Novartis AG (NOVN) CHF50 (regd)

Sell:98.15 CHFBuy:98.16 CHF1.49 CHF (1.54%)

Prices delayed by at least 15 minutes
Sell:98.15 CHF
Buy:98.16 CHF
Change:1.49 CHF (1.54%)
Deal now
Prices delayed by at least 15 minutes
Sell:98.15 CHF
Buy:98.16 CHF
Change:1.49 CHF (1.54%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.

Key people

Vasant Narasimhan
Chief Executive Officer, Member of the Executive Committee
Harry Kirsch
Chief Financial Officer, Member of the Executive Committee
Shreeram Aradhye
President - Global Drug Development and Chief Medical Officer, Member of the Executive Committee
Victor Bulto
President - US, Member of the Executive Committee
Patrick Horber
President - International, Member of the Executive Committee
Steffen Lang
President - Operations, Member of the Executive Committee
Fiona H. Marshall
President - Biomedical Research, Member of the Executive Committee
Robert Kowalski
Chief People and Organization Officer, Member of the Executive Committee
Klaus Moosmayer
Chief Ethics, Risk and Compliance Officer, Member of the Executive Committee
Aaron Gal
Chief Strategy and Growth Officer, Member of the Executive Committee
Joerg Reinhardt
Independent Non-Executive Chairman of the Board
Simon E. Moroney
Independent Non-Executive Vice Chairman of the Board
Patrice Bula
Non-Executive Lead Independent Director
Nancy C. Andrews
Non-Executive Independent Director
Ton Buechner
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    Switzerland
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    CH0012005267
  • Market cap
    CHF 211.68bn
  • Employees
    75,883
  • Shares in issue
    2.19bn
  • Exchange
    SIX Swiss Exchange
  • Index
    Swiss Market Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.